Tong Ren Tang Technologies Co. Ltd.

1666

CNE100000585

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:38:20 14/05/2024 pm IST			5-day change	1st Jan Change
5.79 ^HKD	-1.03%		+4.70%	-11.60%

30/04	Beijing Tong Ren Tang Gets Nod to Sell Fever Drug in Hong Kong	MT
22/03	Tong Ren Tang Technologies Co. Ltd. Announces Final Ordinary Dividend for the Financial Year End 31 December 2023. Payable on August 9, 2024	CI

Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 14 August 2023

March 22, 2023 at 03:03 pm IST

Tong Ren Tang Technologies Co. Ltd. proposes final dividend of RMB 0.16 per share for the year ended 31 December 2022, payable on 14 August 2023. Ex-dividend date 19 June 2023 and Record date 26 June 2023.

Latest news about Tong Ren Tang Technologies Co. Ltd.

Beijing Tong Ren Tang Gets Nod to Sell Fever Drug in Hong Kong	30/04	MT
Tong Ren Tang Technologies Co. Ltd. Announces Final Ordinary Dividend for the Financial Year End 31 December 2023. Payable on August 9, 2024	22/03	CI
Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03	CI
China Permits Clinical Trial of Tong Ren Teng's Anti-Blood Stasis Drug	05/03	MT
Tong Ren Tang Technologies Co. Ltd. Receives Notice of Approval for Clinical Trial of Medicine	05/03	CI
Tong Ren Tang Technologies' 2023 Profit to Slip Up to 7%	30/01	MT
Tong Ren Tang Technologies Co. Ltd. Provides Earnings Guidance for the Twelve Months Ended 31 December 2023	29/01	CI
Tong Ren Tang Technologies Co. Ltd. Announces Board Changes	22/01	CI
Beijing Tong Ren Tang Appoints Chairman	13/12	MT
Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Gu Hai Ou as Executive Director, Chairman of the Board, Chairman of the Nomination Committee, Chairman of the Strategy and Planning Committee	13/12	CI
Beijing Tong Ren Tang to Vote Dec. 27 on Renewal of Distributorship Contracts	05/12	MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Proposes New Exclusive Distributorship Framework Agreements	29/11	CI
Tong Ren Tang Logs 514 Million Yuan in Nine-Month Profit	26/23/26	MT
Tong Ren Tang Technologies' Profit Rises 16% in H1	25/23/25	MT
Tong Ren Tang Technologies Co. Ltd. Announces Board Changes	25/23/25	CI
Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
Tong Ren Tang to Log Up to 17% Rise in H1 Profit	04/23/04	MT
Tong Ren Tang Technologies Co. Ltd. Provides Revenue Guidance for the Six Months Ended 30 June 2023	04/23/04	CI
Tong Ren Tang Technologies Co. Ltd. Announces Board Changes	15/23/15	CI
Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2022, Payable on 14 August 2023	15/23/15	CI
Tong Ren Tang Technologies Co. Ltd. Announces Change in Joint Company Secretaries	27/23/27	CI
Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended 31 December 2022	27/23/27	CI
Tong Ren Tang Technologies' Profit Jumps 15% in 2022	22/23/22	MT
Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 14 August 2023	22/23/22	CI
Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	22/23/22	CI

Chart Tong Ren Tang Technologies Co. Ltd.

Duration

Period

Chart Tong Ren Tang Technologies Co. Ltd.

More charts

Company Profile

Tong Ren Tang Technologies Co Ltd is a China-based company mainly engaged in the manufacture and sale of traditional Chinese medicine products. The Company's main businesses includes the production, retail and wholesale of traditional Chinese medicine products and health care products and the provision of traditional Chinese medicine diagnosis and treatment services. The Company is also engaged in the production, processing and acquisition of Chinese herbal medicines, drug sales, medical services and advertising. The Company mainly distributes its products in the domestic market and overseas markets.

Sector

Pharmaceuticals

Calendar

28/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Tong Ren Tang Technologies Co. Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

5.36 CNY

Average target price

6.058 CNY

Spread / Average Target

+13.01%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
TONG REN TANG TECHNOLOGIES CO. LTD.	-11.60%	949M
DONG-E-E-JIAO CO.,LTD.	+44.36%	6.34B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-13.52%	4.61B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+10.85%	3.39B
TASLY PHARMACEUTICAL GROUP CO., LTD	-6.52%	3.29B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+51.14%	2.02B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-5.22%	1.73B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+1.29%	1.67B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+57.69%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-9.67%	1.59B

Alternative Medicine